Recommend Channels to your librarian for 2008. Download form here.
Sign up for Table of Contents Alerts.
Email this page
Print this page
Addenda
Selective Downregulation of the BKβ1 Subunit in Diabetic Arteriolar Myocytes
Mary K. McGahon, Xiaohong Zhang, C. Norman Scholfield, Timothy M. Curtis and J. Graham McGeown
volume 1 | issue 3
May/June 2007Pages: 141 - 143
This is an open-access article
If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
Diabetic retinopathy is an important cause of visual loss. Functional abnormalities including vasoconstriction precede structural changes. Using the streptozotocin-model of diabetes in rats, we have identified down-regulation of the β1 subunit of the BK channel in arteriole myocytes as a possible molecular mechanism underlying these early changes. BKβ1 mRNA levels were reduced as early as 1 month after induction of diabetes, and BK Ca2+-sensitivity and caffeine-evoked BK currents were reduced at 3 months. This effect appears to be selective for the regulatory subunit, as BKα subunit expression was not altered at the mRNA level, and voltage-activated BK currents were unaltered. No changes were seen in voltage activated Ca2+-current, Ca2+-activated Cl--current, or A-type voltage activated K+-currents. Reduced Ca2+-activated BK activity may promote depolarization, Ca2+-channel activation and increased contraction under resting conditions or in response to Ca2+-mobilizing agonists.
Authors
Mary K. McGahon
Centre for Vision Sciences; School of Biomedical Sciences; The Queen's University of Belfast, Institute of Clinical Sciences; The Royal Victoria Hospital; Belfast, UK
Xiaohong Zhang
Centre for Vision Sciences; School of Biomedical Sciences; The Queen's University of Belfast, Institute of Clinical Sciences; The Royal Victoria Hospital; Belfast, UK
C. Norman Scholfield
Cell and Metabolic Signaling Group; School of Medicine and Dentistry; The Queen's University of Belfast; Belfast, UK
Timothy M. Curtis
Centre for Vision Sciences; School of Biomedical Sciences; The Queen's University of Belfast, Institute of Clinical Sciences; The Royal Victoria Hospital; Belfast, UK
J. Graham McGeown
Cell and Metabolic Signaling Group; School of Medicine and Dentistry; The Queen's University of Belfast; Belfast, UK
This is an open-access article
If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.







